[Therapy of cerebral infarction by infusion of plasma substitutes].
In a total of 152 cases of severe cerebral infarction intravascular infusion of plasma substitutes was a part of combined therapy. Hemostasis studies in these patients allowed us to detect various degrees of hypercoagulation as a response to hemodilution. In cases of most pronounced post-hemodilution++ hypercoagulation (77 patients) complications, including those of thrombohemorrhagic nature, were increased in rate (74%) with more severe course of cerebral infarction. Of these 77 patients 46 died (59.7%). In 75 cases with no substantial hypercoagulation, the disease had a more benign course with 2 casulties (2.7%). The hemodilution tests should precede the therapeutic use of plasma substitutes in cerebral infarct patients.